Search research articles
Contact Us
Filters
Showing results (61-70 of 68) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 68 results.
The Journal of Clinical Investigation
|
February 18, 2009
The neuropathic potential of anti-GM1 autoantibodies is regulated by the local glycolipid environment in mice
Kay N Greenshields, Susan K Halstead, Femke M P Zitman, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 4, 2013
MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4
Maartje G Huijbers, Wei Zhang, Rinse Klooster, et al.
Brain : a Journal of Neurology
|
March 8, 2012
Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice
Rinse Klooster, Jaap J Plomp, Maartje G Huijbers, et al.
Neuron
|
March 9, 2004
A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression
Arn M J M van den Maagdenberg, Daniela Pietrobon, Tommaso Pizzorusso, et al.
Science Translational Medicine
|
September 18, 2024
ARGX-119 is an agonist antibody for human MuSK that reverses disease relapse in a mouse model of congenital myasthenic syndrome
Roeland Vanhauwaert, Julien Oury, Bernhardt Vankerckhoven, et al.
Scientific Reports
|
May 8, 2023
Development and characterization of agonistic antibodies targeting the Ig-like 1 domain of MuSK
Jamie L Lim, Roy Augustinus, Jaap J Plomp, et al.
Iscience
|
February 3, 2025
Patient-specific therapeutic benefit of MuSK agonist antibody ARGX-119 in MuSK myasthenia gravis passive transfer models
Jamie L Lim, Stine Marie Jensen, Jaap J Plomp, et al.
Annals of Neurology
|
February 27, 2010
High cortical spreading depression susceptibility and migraine-associated symptoms in Ca(v)2.1 S218L mice
Arn M J M van den Maagdenberg, Tommaso Pizzorusso, Simon Kaja, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 68) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 68 results.
The Journal of Clinical Investigation
|
February 18, 2009
The neuropathic potential of anti-GM1 autoantibodies is regulated by the local glycolipid environment in mice
Kay N Greenshields, Susan K Halstead, Femke M P Zitman, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 4, 2013
MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4
Maartje G Huijbers, Wei Zhang, Rinse Klooster, et al.
Brain : a Journal of Neurology
|
March 8, 2012
Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice
Rinse Klooster, Jaap J Plomp, Maartje G Huijbers, et al.
Neuron
|
March 9, 2004
A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression
Arn M J M van den Maagdenberg, Daniela Pietrobon, Tommaso Pizzorusso, et al.
Science Translational Medicine
|
September 18, 2024
ARGX-119 is an agonist antibody for human MuSK that reverses disease relapse in a mouse model of congenital myasthenic syndrome
Roeland Vanhauwaert, Julien Oury, Bernhardt Vankerckhoven, et al.
Scientific Reports
|
May 8, 2023
Development and characterization of agonistic antibodies targeting the Ig-like 1 domain of MuSK
Jamie L Lim, Roy Augustinus, Jaap J Plomp, et al.
Iscience
|
February 3, 2025
Patient-specific therapeutic benefit of MuSK agonist antibody ARGX-119 in MuSK myasthenia gravis passive transfer models
Jamie L Lim, Stine Marie Jensen, Jaap J Plomp, et al.
Annals of Neurology
|
February 27, 2010
High cortical spreading depression susceptibility and migraine-associated symptoms in Ca(v)2.1 S218L mice
Arn M J M van den Maagdenberg, Tommaso Pizzorusso, Simon Kaja, et al.
Page
of 7